With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

The Nasdaq Composite slid more than 3% in Monday’s trading as a slate of AI-related plays, including chip darling Nvidia, ...

Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...

Oil futures resume their rally with winter demand and prospects of supply curbs due to U.S. sanctions pushing prices to their highest level since August. "U.S. sanctions against Russia remain the ...

Despite today's revenue miss, Bernstein stands firm on their long-term outlook for Eli Lilly. This optimism is reflected in the broader analyst consensus, with an average rating of 1.75 (Strong ...

Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check.

Asian stocks are mixed after Wall Street’s mostly positive performance ahead of key U.S. inflation data that could influence the pace of the Federal Reserve’s rate cuts. U.S. futures and ...

Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential ...

Most U.S. stocks rose following an encouraging update on inflation, but drops for Eli Lilly and some other ... in the index were higher. The Dow Jones Industrial Average added 0.5%, and the ...

Shares of Eli Lilly & Co. LLY slipped 6.59% to ... with the S&P 500 Index SPX rising 0.11% to 5,842.91 and the Dow Jones Industrial Average DJIA rising 0.52% to 42,518.28. This was the stock's ...